Ninety-five percent of cases of severe muscular dystrophy with early childhood onset result from mutations in the dystrophin region of the human X chromosome (DMD, McKusick 310200), whereas 5% are thought to result from mutations in autosomal genes. We examined a total of 415 families with at least one living patient whose clinical features suggested DMD. Based on formal genetics, haplotype analysis, and dystrophin determinations, we estimate that one in eight (11.8%) sporadic male patients carries autosomal rather than X chromosomal mutations. (J Med Genet 1995;32:930-933) Duchenne muscular dystrophy (DMD) is one of the most common monogenic disorders; it is caused by X linked recessive mutations at
hood autosomal recessive muscular dystrophy) has recently been classified as LGMD2C and
LGMD2D7 and this nomenclature will be used throughout this paper.
LGMD2 is characterised by normal dystro- of males with a clinical diagnosis of DMD, in whom X linked inheritance had been excluded, are thought to be affected by autosomal recessive muscular dystrophy. The flow chart shown in fig 3 summarises the course and the results of our investigation.
Discussion
For both DMD and the milder form, BMD (Becker muscular dystrophy), an autosomal recessively inherited phenocopy is known. Two important aspects should be taken into account in genetic counselling of families with a sporadic/sib DMD case without a detectable anomaly in the dystrophin gene.
(1) If one assumes that about 5% of all childhood MD cases are caused by autosomal recessive mutations,17 16 -4% of all sporadic/sib cases without a detectable mutation are expected to show the autosomal recessive mode of inheritance. Our own dystrophin data showed normal dystrophin in six of51 (11 8%) patients. A realistic estimate of the proportion of autosomal recessive muscular dystrophy therefore might lie between 11-8% and 16-4%. Sibs of both sexes of these affected males would have a probability of 0-25 of being affected. (2) With regard to sisters of affected males it is important to know whether the defect follows autosomal or X linked inheritance, since the risk for affected sons of these sisters differs
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? XX:25%x 118%=29% in sporadic/sib cases we strongly recommend taking a muscle biopsy for dystrophin analysis. A quite frequent situation in clinical practice is the lack of dystrophin determination in sporadic cases without evidence for a detectable structural anomaly in the dystrophin gene. In such cases, the following considerations apply (fig 4) .
In the situation illustrated in fig 4, female offspring would carry a risk of 25% (a priori probability for autosomal recessive inheritance) multiplied by 11 8% (posterior probability for autosomal recessive inheritance), that is, 2-9%. Male offspring would carry a risk of 45% (X linked inheritance, assuming that the mother has a probability of 90% ofbeing heterozygous) multiplied by 88-2% (who were the 45 dystrophin negative patients in our investigation, meaning X linked inheritance) plus 2-9% (the mother and the father are heterozygous for autosomal recessive muscular dystrophy), that is, 42-6%.
In the case that there are two affected male sibs (fig 5) , the risk for an affected son would amount to around 46%, while the risk for an affected girl, assuming autosomal recessive inheritance, does not decrease significantly.
So far there are no reliable published data about the distribution of CK values in heterozygotes in autosomal recessive LGMD. Therefore it would seem to be important to determine CK levels of all mothers and fathers of a sporadic/sib DMD case, in whom no detectable anomaly in Xp21 or dystrophin in muscle biopsy is found.
